Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
129.46
0.00 (0.00%)
Jul 17, 2025, 4:00 PM - Market closed

Blueprint Medicines Stock Forecast

Stock Price Forecast

The 18 analysts that cover Blueprint Medicines stock have a consensus rating of "Buy" and an average price target of $128.87, which forecasts a -0.46% decrease in the stock price over the next year. The lowest target is $105 and the highest is $138.

Price Target: $128.87 (-0.46%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$105$128.87$129$138
Change-18.89%-0.46%-0.36%+6.60%
* Price targets were last updated on Jun 17, 2025.

Analyst Ratings

The average analyst rating for Blueprint Medicines stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy676644
Buy788821
Hold56661413
Sell000000
Strong Sell111100
Total192221212018

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Hold
Downgrades
$143$129
HoldDowngrades$143$129-0.36%Jun 17, 2025
Morgan Stanley
Morgan Stanley
Hold
Maintains
$102$129
HoldMaintains$102$129-0.36%Jun 5, 2025
UBS
UBS
Hold
Maintains
$88$129
HoldMaintains$88$129-0.36%Jun 5, 2025
Citigroup
Citigroup
Hold
Upgrades
$83$129
HoldUpgrades$83$129-0.36%Jun 4, 2025
JMP Securities
JMP Securities
Hold
Downgrades
n/a
HoldDowngradesn/an/aJun 3, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
735.04M
from 508.82M
Increased by 44.46%
Revenue Next Year
975.99M
from 735.04M
Increased by 32.78%
EPS This Year
-0.91
from -1.07
EPS Next Year
0.99
from -0.91
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
793.74M180.08M204.04M249.38M508.82M735.04M975.99M1.21B
Revenue Growth
1,093.37%-77.31%13.30%22.22%104.04%44.46%32.78%24.08%
EPS
5.59-11.01-9.35-8.37-1.07-0.910.994.23
EPS Growth
-------328.73%
Forward PE
------131.1830.60
No. Analysts
-----232320
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High811.7M1.1B1.4B
Avg735.0M976.0M1.2B
Low692.4M841.8M904.4M

Revenue Growth

Revenue Growth20252026202720282029
High
59.5%
45.0%
47.6%
Avg
44.5%
32.8%
24.1%
Low
36.1%
14.5%
-7.3%

EPS Forecast

EPS20252026202720282029
High1.243.227.85
Avg-0.910.994.23
Low-2.05-1.921.56

EPS Growth

EPS Growth20252026202720282029
High--
695.8%
Avg--
328.7%
Low--
57.9%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.